logo

Adagio Therapeutics, Inc. (ADGI)



Trade ADGI now with
  Date
  Headline
7/5/2022 8:31:50 AM Adagio Therapeutics Names David Hering Permanent CEO And Director
3/30/2022 6:38:10 AM Adagio Therapeutics Says Phase 2/3 Data From EVADE And STAMP Meet Primary Endpoints
9/29/2021 7:22:19 AM Adagio Reports New Data From COVID-19 Program; Says ADG20 Continues To Be Well Tolerated In Healthy Volunteers
9/20/2021 6:39:25 AM Adagio Therapeutics Q2 Net Loss $44.7 Mln Or $0.18/Shr; Provides COVID-19 Antibody Program Updates